• Slider Image
  • Slider Image
  • Slider Image

In the Press

April 18, 2019

Nigeria nears clinical trials for stem cell therapies

The article features research from Dr. Dan Kaufman: after extensive preclinical testing, the US Food and Drug Administration (FDA) gave Dr. Kaufman and Fate Therapeutics the go-ahead last November to set up a phase I clinical trial to test their iPS-derived NK immunotherapy in people with advanced solid tumours.


April 12, 2019

Nigeria nears clinical trials for stem cell therapies

Fate Therapeutics begins experimental testing of ‘natural killer’ cells in cancer, working closely with expert Dr. Dan Kaufman. The first patient, Derek Ruff, was treated by Dr. Sandip Patel for his recurrent stage four colon cancer.


April 3, 2019

Family colon cancer risk similar for siblings and half siblings

Siblings of people with colorectal cancer are themselves at higher risk for the disease - but a new study suggests half-siblings face nearly as a high a risk. Joshua Demb, a researcher with the Moores Cancer Center at the University of California, San Diego and the San Diego Veterans Affairs Healthcare System comments on the study.


April 1, 2019

Federal Study Gives New Options for People With Rare Cancers

Rare cancers individually affect fewer than 6 in 100,000 people a year, but collectively make up 22% of all cancer cases. This study was led by Drs. Razelle Kurzrock and Sandip Patel.


April 1, 2019

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

Fate Therapeutics, in collaboration with UC San Diego researcher Dr. Dan Kaufman, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.


March 28, 2019

New drugs that unleash the immune system on cancers may backfire, fueling tumor growth

Dr. Razelle Kurzrock and her team treated a patient with a checkpoint inhibitor that blocks PD-L1 which can stoke tumor growth.


March 27, 2019

The 2019 Xconomy Awards San Diego Finalists Are...

Dr. Razelle Kurzrock was nominated as Precision Medicine Leader in X of the Year.


March 21, 2019

Ironman veterans team up to beat common foe: pancreatic cancer

Ironman World Champion Kathleen McCartney along with pancreatic cancer survivor Mike Levine regularly meet with his doctor Dr. Paul Fanta and his other pancreatic cancer patients to offer inspiration about never giving up.


March 7, 2019

How the Microbiome Could Be the Key to New Cancer Treatments

The effectiveness of drugs that help the immune system fight cancer cells appears to depend on bacteria in the gut, featuring research from Dr. Rob Knight.


March 4, 2019

Poison Drummer Rikki Rockett, an HPV-Attributed Throat Cancer Survivor, Urges Public to Open Up and Say Ahhh! and GET SCREENED During the 21st Annual Oral, Head and Neck Cancer Awareness Week®

Ezra Cohen, MD, is Rockett's physician and Board Member of the Head and Neck Cancer Alliance (HNCA).


March 4, 2019

Vaccine could halt the spread of metastatic cancer

Ezra Cohen, MD and researchers at the UC San Diego Health and the La Jolla Institute for Allergy and Immunology are working on a cancer vaccine that’s specific for each patient. It’s a clinical trial that is only for people with metastatic cancer.


March 1, 2019

UC San Diego researcher gets $4 million NCI Award to study cancer drug resistance

The National Cancer Institute (NCI) has awarded David Cheresh, PhD, Distinguished Professor and vice chair of Pathology at University of California San Diego School of Medicine, with a $4.2 million Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.


February 8, 2019

Firefighters and the Cancer Beast

Firefighters and others depend on scientists for innovations in prevention and treatment, and have mentioned our annual Industry/Academia Translational Oncology Symposium as an example of fosering new partnerships to speed new therapies to patients.


January 24, 2019

John Mendelsohn, shaper of UC San Diego's renowned cancer program, dies at 82

This profile features Drs. Scott Lippman and Razelle Kurzrock, leaders of the Cancer Center.


January 5, 2019

Healthy Living: Cancer deaths drop in U.S.

According to a study by the American Cancer Society, deaths from cancer have dropped steadily for 25 straight years, and Dr. James Murphy gives his expert opinion.


January 5, 2019

Stopping cancer from recruiting immune system double agents

Researchers, led by senior author Judy Varner, PhD, find a novel intervention that keeps tumors from enlisting myeloid cells to help them grow and spread.


January 3, 2019

An Errant Editing Enzyme Promotes Tumor Suppressor Loss and Leukemia Propagation

A research team led by senior author Dr. Catriona Jamieson found that the normal functions of the ADAR1 enzyme are hijacked by pre-malignant cells, leading to a cascade of molecular consequences that promote malignant transformation, dormant cancer stem cell generation and resistance to treatment.


January 2, 2019

Frontline Cancer: The season for family, health, hope and new beginnings

The Moores Cancer Center at UC San Diego Health is one of just a small group of centers worldwide that treat a high volume of GIST cases each year.


January 2, 2019

For biomedical industry, partial government shutdown a New Year's headache

UC San Diego researcher/oncologist Dr. Catriona Jamieson said that while work is currently moving ahead, a prolonged shutdown will increasingly interfere with research.


January 1, 2019

How personalized medicine is transforming your healthcare

This month's issue of National Geographic magazine features the story of Teresa McKeown, a patient advocate who will be speaking at our upcoming "Next Generation Precision Oncology" Symposium next month.


December 22, 2018

n=30 Next Step in Cancer Therapy: Personalized Vaccine?

The podcast features Tamara Strauss, the first patient to enroll in a first-of-its-kind clinical trial at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.


December 19, 2018

Preventing Pancreatic Cancer: A Q&A with Surgical Oncologist Andrew Lowy, MD

Led by Dr. Andrew Lowy, along with a multidisciplinary team with expertise in genetics, imaging, endoscopic procedures, surgery and nutrition, UC San Diego Health is creating a first-of-its-kind clinic to develop personalized prevention and early detection plans for high-risk patients seeking care at San Diego’s only NCI-designated Comprehensive Cancer Center.


December 13, 2018

Cash running short, California's stem cell agency defends its results

The California Institute for Regenerative Medicine, or CIRM, is drawing down the last of $3 billion in state bond money granted by voters in 2004 with Proposition 71. Article features MCC oncologist/researcher and CIRM grantee Dr. Catriona Jamieson.


» More Press


2019 Symposium


The 15th Moores Cancer Center Industry/Academia "Next Generation Precision Oncology" Symposium was held on Thursday, February 21, 2019. View the photo gallery for the highlights here.

Click to view full Agenda of the day:



2018 Symposium Featured Talks


The 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. See the Agenda here.


Keynote Presentation: Duane Roth Award Lecture
Engineering T-Cells: The Sky is the Limit


Carl June, MD
University of Pennsylvania School of Medicine




Keynote Presentation:
A New Model for Translational Research in the Nonprofit Sector


Peter Schultz, PhD
California Institute for Biomedical Research



Welcome Remarks


Ida Deichaite, PhD, Symposium Organizer, UC San Diego Moores Cancer Center
Pradeep Khosla, PhD, Chancellor, UC San Diego



Welcome Remarks


Thomas Kipps, MD, PhD
Symposium Chair, UC San Diego Moores Cancer Center





In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of prevision medical oncology; proof of concept


Donald Durden, MD, PhD
UC San Diego Moores Cancer Center


Visit our Symposium page for more Symposium Featured Talks.





2015 Symposium Slideshow



Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!



2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives



San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.



The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here


Our Symposium Page




9th Symposium Featured on San Diego ABC 10 News




San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press